Anastrozole Tablet
Product Images NDC 87063-224

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 8 technical images submitted to the FDA as part of the official labeling for Anastrozole (NDC 87063-224). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Asclemed Usa Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure For Anastrozole (Image 01)

FDA Label Image

Figure 1 (Image 02)

Figure 1 (Image 02)
This text appears to be a description of a clinical study comparing randomized treatment with anastrozole and tamoxifen. The data presented shows disease-free survival rates over different time points in months for a certain number of patients on each treatment. The text also includes the number of patients at risk for each treatment group at various time points. This information may be useful for analyzing the effectiveness of anastrozole and tamoxifen in treating a particular condition.*
FDA Label Image

Figure 2 (Image 03)

FDA Label Image

Figure 3 (Image 04)

Figure 3 (Image 04)
Not available.*
FDA Label Image

Figure 4 (Image 05)

Figure 4 (Image 05)
This appears to be a medical document presenting data related to a randomized treatment comparison between two medications, Anastrozole and Tamoxifen. The document includes a graph showing a survival analysis over a specified timeline in months, with the number of patients at risk listed at different time points. The text also mentions the truncation of the vertical axis for clarity in interpreting the Kaplan-Meier curves.*
FDA Label Image

Figure 5 (Image 06)

FDA Label Image

Figure 6 (Image 07)

FDA Label Image

Label (Label)

Label (Label)
This text appears to be a description of Enovachem's Anastrozole Tablets in various dosages (1 mg) and packaging (NDC numbers: 67063-224-90, 67063-224-30, 67063-224-60). It includes some technical details and references such as patent numbers and regulatory codes. The tablets are USP approved and seem to be part of a pharmaceutical product line.*

* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.